V030-5785 Screening compound: 4-[6-(3-chlorobenzenesulfonyl)-4-(4-methylpiperazin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine

V030-5785 Screening compound: 4-[6-(3-chlorobenzenesulfonyl)-4-(4-methylpiperazin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine
V030-5785 Screening compound: 4-[6-(3-chlorobenzenesulfonyl)-4-(4-methylpiperazin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound V030-5785
4-[6-(3-chlorobenzenesulfonyl)-4-(4-methylpiperazin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V030-5785

Molecular Formula

C22H29ClN6O3S (C22 H29 ClN6 O3 S)

Compound Name

4-[6-(3-chlorobenzenesulfonyl)-4-(4-methylpiperazin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine

IUPAC name

4-[6-(3-chlorobenzenesulfonyl)-4-(4-methylpiperazin-1-yl)-5H6H7H8H-pyrido[43-d]pyrimidin-2-yl]morpholine

SMILES

CN(CC1)CCN1c1c(CN(CC2)S(c3cccc(Cl)c3)(=O)=O)c2nc(N2CCOCC2)n1

InChI

InChI=1S/C22H29ClN6O3S/c1-26-7-9-27(10-8-26)21-19-16-29(33(30,31)18-4-2-3-17(23)15-18)6-5-20(19)24-22(25-21)28-11-13-32-14-12-28/h2-4,15H,5-14,16H2,1H3

InChI Key

XQTXXUHFQXPLGJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19908857

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

493.03

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.060

Distribution Coefficient, logD

1.880

Water Solubility, LogSw

-3.46

Polar Surface Area

68.833

Acid Dissociation Constant (pKa)

20.31

Base Dissociation Constant (pKb)

8.55

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

54.54

V030-5785 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

PI3K-Targeted Library (17255 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Akt-Targeted Library (14764 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

New Agro Library (44492 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Others
  • Kinases
Mechanism of action:
  • Epigenetic
Agro:
  • Agro

References: we are preparing a list of scientific research reports with V030-5785 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V030-5785?
Check Price and Availability of V030-5785, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V030-5785 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V030-5785
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V030-5785
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V030-5785 available by request